Literature DB >> 3546323

Fibrous dysplasia. An analysis of options for treatment.

R B Stephenson, M D London, F M Hankin, H Kaufer.   

Abstract

The results of treatment of sixty-five symptomatic lesions in forty-three patients who had fibrous dysplasia were reviewed. For fourteen (93 per cent) of the fifteen times that a lesion in the upper extremity was treated non-operatively, the result was satisfactory. These results were independent of the patient's age when first seen. In contrast, in the lower extremity, the results were highly dependent on the age of the patients at the time of the initial presentation of symptoms. In patients who were eighteen years old or older, eight (88 per cent) of the nine times that a lesion involving the lower extremity had closed treatment and both times that a lesion was treated with curettage and bone-grafting, the result was satisfactory. The results of these modalities of treatment in patients who were less than eighteen years old were discouraging. Twenty-eight (88 per cent) of the thirty-two times that closed treatment was used and twenty-five (81 per cent) of the thirty-one times that curettage and bone-grafting was used, the result was unsatisfactory. However, after eighteen (86 per cent) of the twenty-one times that a lesion in the lower extremity was treated by internal fixation in a patient who was less than eighteen years old, there was a satisfactory outcome. We concluded that closed treatment of a symptomatic lesion in the upper extremity generally provides satisfactory results. In patients who are less than eighteen years old, neither closed treatment nor curettage and bone-grafting is adequate treatment for a symptomatic lesion in the lower extremity. Internal fixation should be strongly considered in these young patients.

Entities:  

Mesh:

Year:  1987        PMID: 3546323

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  23 in total

1.  Fibular strut grafting for fibrous dysplasia of the femoral neck.

Authors:  D D Bryant; R E Grant; D Tang
Journal:  J Natl Med Assoc       Date:  1992-10       Impact factor: 1.798

2.  Monostotic fibrous dysplasia of the distal radius metaphysis: case report.

Authors:  Jessica N Moseley; Jeffrey B Friedrich
Journal:  Hand (N Y)       Date:  2011-02-18

3.  Monostotic fibrous dysplasia of a cervical vertebra.

Authors:  C Villas; R Martínez-Peric
Journal:  Eur Spine J       Date:  1992-09       Impact factor: 3.134

4.  Fibrous dysplasia of bone: Surgical management options and outcomes of 22 cases.

Authors:  Xiang Fang; Hongyuan Liu; Yun Lang; Yan Xiong; Hong Duan
Journal:  Mol Clin Oncol       Date:  2018-05-21

5.  Intramedullary rod fixation of fibrous dysplasia without use of bisphosphonates.

Authors:  Greg Gaski; Dane Hansen; Leisel M Willis; Gary D Bos; John R Kean
Journal:  J Child Orthop       Date:  2013-09-03       Impact factor: 1.548

6.  Fibrous dysplasia in axis treated with vertebroplasty.

Authors:  Kadir Kotil; Emine Ozyuvaci
Journal:  J Craniovertebr Junction Spine       Date:  2010-07

7.  C2/C3 pathologic fractures from polyostotic fibrous dysplasia of the cervical spine treated with percutaneous vertebroplasty.

Authors:  David Dang; Mirza N Baig; Greg Christoforidis; E Antonio Chiocca; Joshue Gabriel
Journal:  Eur Spine J       Date:  2007-07-31       Impact factor: 3.134

8.  Bone-Grafting in Polyostotic Fibrous Dysplasia.

Authors:  Arabella I Leet; Alison M Boyce; Khalda A Ibrahim; Shlomo Wientroub; Harvey Kushner; Michael T Collins
Journal:  J Bone Joint Surg Am       Date:  2016-02-03       Impact factor: 5.284

9.  Case report 784: Fibrous dysplasia of the second pedal digit.

Authors:  V Vigorita; F D'Ambrosio; R Verde; C Kauderer; E Bryk
Journal:  Skeletal Radiol       Date:  1993-08       Impact factor: 2.199

Review 10.  [Benign tumours and tumour-like lesions of the bone : General treatment principles].

Authors:  H Fritzsche; K-D Schaser; C Hofbauer
Journal:  Orthopade       Date:  2017-06       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.